Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

Related Citations for PubMed (Select 18508817)

1.

The lectin-like domain of thrombomodulin protects against ischaemia-reperfusion lung injury.

Geudens N, Van de Wouwer M, Vanaudenaerde BM, Vos R, Van De Wauwer C, Verleden GM, Verbeken E, Lerut T, Van Raemdonck DE, Conway EM.

Eur Respir J. 2008 Oct;32(4):862-70. doi: 10.1183/09031936.00157107. Epub 2008 May 28.

2.

The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis.

Van de Wouwer M, Plaisance S, De Vriese A, Waelkens E, Collen D, Persson J, Daha MR, Conway EM.

J Thromb Haemost. 2006 Aug;4(8):1813-24.

PMID:
16879225
3.

The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways.

Conway EM, Van de Wouwer M, Pollefeyt S, Jurk K, Van Aken H, De Vriese A, Weitz JI, Weiler H, Hellings PW, Schaeffer P, Herbert JM, Collen D, Theilmeier G.

J Exp Med. 2002 Sep 2;196(5):565-77.

4.

Thrombomodulin's lectin-like domain reduces myocardial damage by interfering with HMGB1-mediated TLR2 signalling.

Herzog C, Lorenz A, Gillmann HJ, Chowdhury A, Larmann J, Harendza T, Echtermeyer F, Müller M, Schmitz M, Stypmann J, Seidler DG, Damm M, Stehr SN, Koch T, Wollert KC, Conway EM, Theilmeier G.

Cardiovasc Res. 2014 Mar 1;101(3):400-10. doi: 10.1093/cvr/cvt275. Epub 2013 Dec 9.

5.

The lectin-like domain of thrombomodulin hampers host defence in pneumococcal pneumonia.

Schouten M, de Boer JD, van 't Veer C, Roelofs JJ, Meijers JC, Levi M, Conway EM, van der Poll T.

Eur Respir J. 2013 Apr;41(4):935-42. doi: 10.1183/09031936.00015212. Epub 2012 Aug 30.

6.

Recombinant lectin-like domain of thrombomodulin suppresses vascular inflammation by reducing leukocyte recruitment via interacting with Lewis Y on endothelial cells.

Lin WL, Chang CF, Shi CS, Shi GY, Wu HL.

Arterioscler Thromb Vasc Biol. 2013 Oct;33(10):2366-73. doi: 10.1161/ATVBAHA.113.301221. Epub 2013 Aug 15. Erratum in: Arterioscler Thromb Vasc Biol. 2013 Nov;33(11):e135.

7.

Thermotolerance induces heat shock protein 72 expression and protects against ischaemia-reperfusion-induced lung injury.

Javadpour M, Kelly CJ, Chen G, Stokes K, Leahy A, Bouchier-Hayes DJ.

Br J Surg. 1998 Jul;85(7):943-6.

PMID:
9692569
9.

Azithromycin reduces airway inflammation in a murine model of lung ischaemia reperfusion injury.

Geudens N, Timmermans L, Vanhooren H, Vanaudenaerde BM, Vos R, Van De Wauwer C, Verleden GM, Verbeken E, Lerut T, Van Raemdonck DE.

Transpl Int. 2008 Jul;21(7):688-95. doi: 10.1111/j.1432-2277.2008.00670.x. Epub 2008 Apr 23.

PMID:
18435685
10.

The lectin-like domain of thrombomodulin ameliorates diabetic glomerulopathy via complement inhibition.

Wang H, Vinnikov I, Shahzad K, Bock F, Ranjan S, Wolter J, Kashif M, Oh J, Bierhaus A, Nawroth P, Kirschfink M, Conway EM, Madhusudhan T, Isermann B.

Thromb Haemost. 2012 Dec;108(6):1141-53. doi: 10.1160/TH12-07-0460. Epub 2012 Sep 26.

PMID:
23014597
11.

Early tumor necrosis factor-alpha release from the pulmonary macrophage in lung ischemia-reperfusion injury.

Naidu BV, Woolley SM, Farivar AS, Thomas R, Fraga CH, Goss CH, Mulligan MS.

J Thorac Cardiovasc Surg. 2004 May;127(5):1502-8.

PMID:
15116014
12.
13.

The effects of recombinant human granulocyte-colony stimulating factor on vascular dysfunction and splanchnic ischaemia-reperfusion injury.

Squadrito F, Altavilla D, Squadrito G, Campo GM, Ioculano M, Ammedolia L, Arlotta M, Saitta A, Caputi AP.

Br J Pharmacol. 1997 Jan;120(2):333-9.

14.

Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide.

Rijneveld AW, Weijer S, Florquin S, Esmon CT, Meijers JC, Speelman P, Reitsma PH, Ten Cate H, van der Poll T.

Blood. 2004 Mar 1;103(5):1702-9. Epub 2003 Oct 30.

15.

Effects of a novel peptide derived from human thrombomodulin on endotoxin-induced uveitis in vitro and in vivo.

Jin H, Yang X, Liu K, Gu Q, Xu X.

FEBS Lett. 2011 Nov 4;585(21):3457-64. doi: 10.1016/j.febslet.2011.10.002. Epub 2011 Oct 10.

16.
17.

Granulocyte macrophage-colony stimulating factor (GM-CSF) augments acute lung injury via its neutrophil priming effects.

Choi JC, Jung JW, Kwak HW, Song JH, Jeon EJ, Shin JW, Park IW, Choi BW, Kim JY.

J Korean Med Sci. 2008 Apr;23(2):288-95. doi: 10.3346/jkms.2008.23.2.288.

18.

Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain.

Horowitz NA, Blevins EA, Miller WM, Perry AR, Talmage KE, Mullins ES, Flick MJ, Queiroz KC, Shi K, Spek CA, Conway EM, Monia BP, Weiler H, Degen JL, Palumbo JS.

Blood. 2011 Sep 8;118(10):2889-95. doi: 10.1182/blood-2011-03-341222. Epub 2011 Jul 25.

19.

Pretreatment with granulocyte colony-stimulating factor attenuated renal ischaemia and reperfusion injury via activation of PI3/Akt signal pathway.

Li Y, Wu J, Shou Z, He Q, Zhang P, Han F, Li H, Chen J.

Nephrology (Carlton). 2008 Dec;13(6):508-16. doi: 10.1111/j.1440-1797.2008.00928.x. Epub 2008 Mar 5.

PMID:
18331437
20.

Endothelin receptor antagonism by tezosentan attenuates lung injury induced by aortic ischemia-reperfusion.

Kiriş I, Narin C, Gülmen S, Yilmaz N, Sütçü R, Kapucuoğlu N.

Ann Vasc Surg. 2009 May-Jun;23(3):382-91. doi: 10.1016/j.avsg.2008.10.003. Epub 2009 Jan 9.

PMID:
19135850
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk